Babylon stock price rose 20% amid acquisition rumors

Digital health company Babylon’s stock price rose 20 percent Aug. 15 amid rumors of a coming acquisition.

Advertisement

The sharp rise in stock price led to the New York Stock Exchange stopping trading of Babylon common stock. Babylon has not had any discussions with a potential acquirer, according to the Aug. 15 Babylon news release.

By the end of the day Aug. 15, the stock had fallen 5 percent as the company attempted to shut down the speculation, according to The Motley Fool.

The acquisition rumors come after Babylon reported strong second-quarter earnings.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.